This kit detects antibodies against acetylcholine receptors (AChR) and muscle-specific kinase (MuSK), which are pivotal in diagnosing MG. By providing a reliable and efficient method for antibody detection, it enables them to accurately diagnose and initiate appropriate treatments for myasthenia gravis, leading to better management of the disease and improved patient outcomes.